Expert Opinion. Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians different from Caucasians?

بواسطة Tan DSY
منشور في 2020

Letter regarding Article, "Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention"

بواسطة Aw JWX, Tan DSY, Goh LL
منشور في 2020

Patients' and Caregivers' Attitudes Towards Deprescribing in Singapore

بواسطة Kua, C.H., E. Reeves, Tan DSY
منشور في 2020

Switching of P2Y12 Inhibitors in Acute Coronary Syndromes

بواسطة Leong WQ, Kim JH, Aw JWX, Tan DSY
منشور في 2020

Sex Differences in 1-Year Rehospitalisation for Heart Failure and Myocardial Infarction after Primary Percutaneous Coronary Intervention

بواسطة Zheng HL, Foo LL, Tan HC, Tan DSY
منشور في 2020

Association between total daily doses with duration of hospitalization among readmitted patients in a multi ethnic asian population

بواسطة Teo V, Toh MR, Kwan YH, Raaj S, Tan DSY, Tan JZY
منشور في 2020

Asian study of clopidogrel (ASCLOP) responsiveness: The contributions of genetic and non-genetic factors

بواسطة Tan, D.S.Y., Yeo, A.H.L., Ho, H.K., Wee, H.L., Ong, H.Y.
منشور في 2014